The Leading eBooks Store Online
for Kindle Fire, Apple, Android, Nook, Kobo, PC, Mac, BlackBerry...
New to eBooks.com?Learn more
- Bestsellers - This Week
- Foreign Language Study
- Bestsellers - Last 6 months
- Graphic Books
- Health & Fitness
- Political Science
- Biography & Autobiography
- Psychology & Psychiatry
- Body Mind & Spirit
- House & Home
- Business & Economics
- Children's & Young Adult Fiction
- Juvenile Nonfiction
- Language Arts & Disciplines
- Crafts & Hobbies
- Science Fiction
- Current Events
- Literary Collections
- Literary Criticism
- Literary Fiction
- Social Science
- The Environment
- Sports & Recreation
- Family & Relationships
- Study Aids
- Folklore & Mythology
- Food and Wine
- Performing Arts
- True Crime
- Foreign Language Books
Most popular at the top
- Springer Milan 2007; US$ 69.99
L?esigenza di chiarire i concetti attuali dell?atopia, che per troppo tempo hanno oscillato tra una primitiva visione squisitamente clinica ed una successiva unicamente immunologica, era matura da tempo. L?avere compreso che il ruolo delle immunoglobuline E non è esaustivo ed avere accettato la salomonica divisione tra atopia intrinseca ed estrinseca,... more...
- CRC Press 2004; US$ 188.95
This comprehensive, definitive, and long overdue reference deals specifically with all the manifestations of latex intolerance including irritation, allergic contact dermatitis, and contact urticaria. Each chapter presents the latest research in skin irritation, contact dermatitis, and contact urticaria. The well-illustrated textbook also covers in-depth... more...
- World Scientific Publishing Company 2014; US$ 18.00
This book is a unique collaboration between a mother of a child with atopic dermatitis (AD) and the doctor who is treating the child — it offers practical information on AD, recent research findings and tackles many aspects of living with eczema that patients have through the conversation between the mother and doctor. Therefore, this book is... more...
- Springer New York 2008; US$ 289.00
Xeroderma pigmentosum (XP), meaning parchment skin and pigmentary dist- bance, is a rare and mostly autosomal recessive genetic disorder that was originally named by two dermatologists, the Austrian Ferdinand Ritter von Hebra and his H- garian son in law Moritz Kaposi in 1874i and 1883. 2 The earliest published record (PubMed) available on the internet... more...
- Springer Berlin Heidelberg 2012; US$ 79.95
This third edition of the essential guide has been extensively revised and updated and includes additional color illustrations. It reflects the rapid expansion in knowledge of the subject due to progress in the chemical, immunological, and clinical fields. more...
- Springer London 2013; US$ 49.99
This book outlines the most common allergens for contact dermatitis in a concise and algorithmic fashion for easy reference, and offers practical tips for patch testing. Includes a diagnostic algorithm/questionnaire. more...
- Springer Berlin Heidelberg 2005; US$ 159.00
In the past decade it has become increasingly clear that psoriatic disease, both of the skin and joints, can be a significant diagnostic and therapeutic challenge for the physician and a debilitating illness for the patient. At the same time, advances in genetics and immunology have increased our understanding of the pathophysiology of psoriasis and... more...
- Birkhäuser Basel 2008; US$ 259.00
Psoriasis is an inherited skin disease that has been diagnosed in 4.5 million adults in the United States. About 10 percent to 30 percent of people with psoriasis also develop psoriatic arthritis, which causes pain, stiffness and swelling in and around the joints. The book reviews the clinical manifestations of these two entities. The main... more...
- Springer Berlin Heidelberg 2010; US$ 129.00
This clinical guide provides a practical and comprehensive review of all types and aspects of urticaria and angioedema important to the clinician. Its content is entirely up-to-date, taking into consideration both current guidelines and all recent literature. more...
- Springer Berlin Heidelberg 2007; US$ 209.00
Pharmaceutical companies are spending increasing amounts of money on drug discovery and development. Nevertheless, attrition rates in clinical development are still very high, and up to 90% of new compounds fail in clinical phase I - III trials, which is partially due to lack of clinical efficacy. This indicates a strong need for highly predictive... more...